Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Li... (date ofthis release and should not be re...)

(Date:11/5/2009)... Transgenomic, Inc. (OTC ...sults for the quarter ended September 30, 2009. Th... tables that follow. ,, Third Quarter 2009 ,... $0.01 per share for the third quarter of 2009 as ...are for the third quarter of 2008. ,, Net sale...

(Date:11/5/2009).... 5 WaferGen Biosystems,...per of state-of-the-art genetic analysis systems, ...joined the company,s Scientific Advisory Board. H...cializing novel molecular diagnostics for cancer d...pment of computational biology systems for several...

(Date:11/5/2009)...Brooke Sanders brings a new look to Pro Repro , ... 5, 2009 -- Professional Reprographics, Orange Cou...is pleased to present Brooke Sanders to the compan...pecialist. The addition of Brooke to the company r...rofessional Reprographics., , ,Brooke brings with ...

(Date:11/4/2009)... Md., Nov. 4 Zyngenia, Inc., a pri...t-generation antibody drug development, today anno...funding from New Enterprise Associates (NEA), one ...capital will be used to create novel, multi-specif...e biological targets with a single agent. The comp...

Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2 Transgenomic, Inc. Reports Third Quarter 2009 Results 3 Transgenomic, Inc. Reports Third Quarter 2009 Results 4 Transgenomic, Inc. Reports Third Quarter 2009 Results 5 Transgenomic, Inc. Reports Third Quarter 2009 Results 6 Transgenomic, Inc. Reports Third Quarter 2009 Results 7 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4 Zyngenia, Inc. Raises $10 Million in Series A Funding 2 Zyngenia, Inc. Raises $10 Million in Series A Funding 3 Zyngenia, Inc. Raises $10 Million in Series A Funding 4

[0] Transgenomic, Inc. Reports Third Quarter 2009 Results [0] WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board [0] Professional Reprographics Hires Recent Cal Poly Grad to Join their Team [0] Zyngenia, Inc. Raises $10 Million in Series A Funding

...ecklenburg region,certainly has not been immune to...unty, the NC Free Clinic Association has seen thei...ally Gilbert, the creator of,Charlotte,s premier h...ng Expo &,Symposium, wants to do something abo...thy lifestyle. But that scenario is,becoming incre...

...mprises Leading Sector Investors Clarus Ventures, ... , Heptares Therapeutics Ltd, the drug discove...upled receptors (GPCRs), announces today it has ra...ce in a successful Series A,private round from thr...Clarus Ventures led the syndicate, which includes ...

...l Academy of Sciences (NAS) congressionally mandat...ciencies in the nation,s forensic science system a...report also calls for the development of accredita...oficiency testing, certification and a code of eth.... , , The report notes that the American Board o...

Other Biology Technology:Charlotte Anti-Aging Expo & Symposium Supports Free Clinics 2 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 2 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 3 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 4 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 5 Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2

Charlotte Anti-Aging Expo & Symposium Supports Free Clinics Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations

(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...

(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...

(Date:11/3/2009)... MADISON, WI, NOVEMBER 4, 2009 -- The world,s g...y among grape variety, human input, and something ...e vineyard site, soil, and climate. , Experts ...nce in a symposium on Wednesday, Nov. 4 in Pittsbu...ll be presented in two parts at the 2009 Annual Me...

Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3 Great wines come from great soils 2 New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 1 New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 2 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 1 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 2 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 3 Preparing the Americas 3A The Outlook for 2009s Emergency Threats 48748 1 Preparing the Americas 3A The Outlook for 2009s Emergency Threats 48748 2

[0] Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality [0] Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors [0] Great wines come from great soils

...rch team has found a new gene associated with the ...utation was specific to a rare form of epilepsy, t...overall epilepsy treatment. , The findings, which...ifferent countries, appear in the Nov. 7 issue of ...ilepsy, nerve cells in the brain signal abnormally...

...le flower per stalk while each stem of a tomato pl...n a new study, published in this week,s issue of t... Lippman and colleagues identify a genetic mechani... the Solanaceae (nightshade) family of plants that...o, petunia, and deadly nightshades. Manipulation o...

...te scientist and economist Jae Edmonds will speak ...re and sequestration in climate stabilization in t...l Conference on Greenhouse Gas Technologies. He is...ent of Energy,s Pacific Northwest National Laborat...the greenhouse gas and carbon management challenge...

Other Biology News:International team discovers gene associated with epilepsy 2 A big bunch of tomatoes? 2 PNNL leadership in carbon sequestration featured at international conference 2

International team discovers gene associated with epilepsy A big bunch of tomatoes?PNNL leadership in carbon sequestration featured at international conference

Rat Anti-Mouse Semaphorin 6B Monoclonal Antibody, Unconjugated, Clone 256537 from R&D Systems

Goat Anti-Human SorCS1 Polyclonal Antibody, Unconjugated from R&D Systems

Rabbit Anti-FMNL Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Goat Anti-Human PLUNC Polyclonal Antibody, Biotin Conjugated from R&D Systems

Biology Products:

Rat Anti-Mouse Semaphorin 6B Monoclonal Antibody, Unconjugated, Clone 256537 from R&D Systems Goat Anti-Human SorCS1 Polyclonal Antibody, Unconjugated from R&D Systems Rabbit Anti-FMNL Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.Goat Anti-Human PLUNC Polyclonal Antibody, Biotin Conjugated from R&D Systems

Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Li...(date ofthis release and should not be re...)